MedPath

Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male Couples

Not Applicable
Recruiting
Conditions
Substance Use
HIV Infections
Interventions
Behavioral: Communication skills training video
Behavioral: Drug use module
Registration Number
NCT05000866
Lead Sponsor
Hunter College of City University of New York
Brief Summary

This study utilizes a randomized controlled trial design to evaluate the efficacy of two intervention components for couples HIV testing and counseling (CHTC): a communication skills training video and a substance use module. Participants are randomized in a full-factorial design to one of 4 conditions: CHTC as usual; CHTC + communication skills training videos; CHTC + substance use module; or CHTC plus both adjunct components.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
480
Inclusion Criteria
  • · Have a main partner who is another male and have been in a relationship for 3 month or longer

    • One participant must be between 17 and 29; Main partner can be any age above 17.

    • One participant must be HIV negative (as confirmed by rapid test)

    • One participant must have used at least 1 drug in the past 90 days (cocaine/crack, opiates, misuse of prescription medication, stimulants, psychedelics, ecstasy, ketamine, GHB)

    • One participant must have engaged in Transmission Risk Behavior (TRB) in the past 90 days

      o Defined as Condom-less Anal Sex (CAS) with a casual partner and/or CAS with a non-monogamous or serodiscordant main partner

    • Live in the NYC or Detroit metropolitan area

    • Speak English

Exclusion Criteria
  • · Any signs of serious mental illness or cognitive deficit

    • History of IPV with their main partner and safety concerns in the current relationship.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
CHTC and communications skills training videoCommunication skills training videoParticipants complete the standard Couples HIV Testing and Counseling session and also watch a communication skills training video together.
CHTC, communications skills training and substance use moduleDrug use moduleParticipants complete the standard Couples HIV Testing and Counseling session and watch a communication skills training video and complete a substance use module together.
CHTC and substance use moduleDrug use moduleParticipants complete the standard Couples HIV Testing and Counseling session and also complete a substance use module together.
CHTC, communications skills training and substance use moduleCommunication skills training videoParticipants complete the standard Couples HIV Testing and Counseling session and watch a communication skills training video and complete a substance use module together.
Primary Outcome Measures
NameTimeMethod
Drug use frequency12 months

Number of reported days of illicit drug use (amphetamines, cocaine/crack, GHB, ketamine or ecstasy) reported on quarterly timeline follow-back assessments

Urine assay for drug use12 months

Positive urine screen for drug use assessed bi-annually

CAS with casual partners12 months

Number of total anal sex acts (insertive and receptive) with casual partners reported on quarterly timeline follow-back assessments

Bacterial STI's12 months

Any chlamydia or gonorrhea diagnosis assessed bi-annually

Secondary Outcome Measures
NameTimeMethod
PrEP Uptake12 months

self-reported receipt of a PrEP-prescription

Binge drinking12 months

Number of days on which 5 or more drinks containing alcohol were reported on the quarterly timeline follow-back interview

Syphilis infection12 months

Reactive RPR test assessed bi-annually

PrEP adherence12 months

taking 4 or more doses weekly as prescribed reported on quarterly timeline follow-back assessments

Trial Locations

Locations (2)

Hunter College

🇺🇸

New York, New York, United States

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath